MPLT R&D Expenses

Maplight Therapeutics Inc · R&D Expenses

MPLT logo

MPLT R&D Expenses

Latest reported$198.70M
MPLT TTM R&D Expenses ($57.90M → $198.70M)
High-resolution chart · PNG

MPLT r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Maplight Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
198,696,000
171,972,000
137,908,000
94,138,000
83,858,000
72,616,000
68,196,000
57,903,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.